Delivery Order SPE2DB24D6044-SPE2DB25FLJKQ
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,244.93 to AmerisourceBergen Drug Corp for the supply of Duloxetine HCL DR 60 mg capsules (1,000 units). This competitively awarded, firm fixed-price delivery order was issued on August 21, 2025, with an ultimate completion date of August 22, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. Duloxetine is a serotonin-norepinephrine reuptake...
- The Defense Logistics Agency awarded a delivery order valued at $8,659.63 to AmerisourceBergen Drug Corp for 1,000 capsules of Duloxetine HCL DR 60 mg, with an ultimate completion date of September 2, 2025. This firm fixed-price delivery order, issued on August 29, 2025, was not set-aside and represents a competitive award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 and extending through December...
- This delivery order, awarded on August 28, 2025, by the Defense Logistics Agency's Medical Supply Chain to AmerisourceBergen Drug Corp, provides 1,000 capsules of Duloxetine HCl 60 mg under a firm fixed-price contract valued at $2,247.82. The order will be completed by August 29, 2025, and performed at the contractor's Conshohocken, Pennsylvania facility. This award represents a non-competitive delivery order issued against AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency valued at $3,022.92 for 1,000 capsules of Duloxetine HCL DR 60 mg. The award, issued on August 20, 2025, with an ultimate completion date of August 21, 2025, carries a firm fixed price and was competitively awarded with no set-aside designation. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $1,919.76 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of 1,000 capsules of Duloxetine HCL DR 20 mg. This non-set-aside contract, which is due for completion by August 13, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the company's corporate office location in...
- This is a $1,543.10 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,567,571,538 units of duloxetine hydrochloride delayed-release 60 mg capsules, a medication used to treat conditions like depression and nerve pain. The contract has a period of performance through March 14, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $1,907.28 and is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that runs through November 2026. The contract is for the supply of Duloxetine Hydrochloride delayed-release capsules, a medication used to treat conditions such as depression,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of 1,000 units of Duloxetine HCL DR 60 mg capsules at a ceiling value of $1,433.94. This is a firm fixed-price delivery order with an ultimate completion date of August 26, 2025, and represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,084.80 to AmerisourceBergen Drug Corp for Duloxetine HCL DR 40 mg capsules (30-count) on August 15, 2025, with completion expected by August 18, 2025. This firm fixed-price, non-set-aside contract is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. As a child order under a larger contract vehicle, this delivery order represents a routine pharmaceutical procurement fulfilling federal medical...
- The U.S. Defense Logistics Agency (DLA) awarded a $5,123.29 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 1,000 units of Duloxetine HCl DR 60 mg capsules. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999, which AmerisourceBergen holds with the DLA Troop Support Medical for providing a comprehensive range of pharmaceutical products and medical supplies to support military...
- SPE2DB24D6044Indefinite Delivery Contract
- SPE2DB24D6044-SPE2DB25FLJKQDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,219.33 to AmerisourceBergen Drug Corp for 1,000 capsules of Duloxetine HCL DR 20 mg, with performance completion scheduled for August 28, 2025. This non-set-aside, competitively awarded contract uses firm fixed pricing and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. Duloxetine is a serotonin-norepinephrine reuptake inhibitor (SNRI) commonly used to treat depression, anxiety, and chronic pain conditions within military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. As a prime pharmaceutical vendor, AmerisourceBergen supplies a comprehensive range of medications and medical supplies to support military healthcare programs globally. The company's role as a critical federal medical procurement vendor demonstrates its established capability to meet DLA requirements for pharmaceutical distribution across multiple therapeutic domains serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 8/27/25 |